top of page

Technology Platforms

Biologics Drug Discovery

Dotquant is developing advanced biologics based on DNA and RNA for targeted therapy and drug delivery. The outstanding specificity of oligonucleotide base-paring and the high degree of flexibility of post-production modifications enable a host of solutions to immunotherapy and anti-sense therapy.


Custom RNA Synthesis

Although we focus on drug discovery and development, we also make our propitiatory in vitro transcription technology available to the broader scientific communities including ncRNAs, aptamers, aptamer-siRNA chimeras, aptamer-microRNA chimeras, CRISPR guides, ribozymes, and microRNAs, where long chemically modified RNAs are needed. We custom synthesize 2’F-modified RNAs of medium to long lengths (60-400 NTs) at affordable prices.

bottom of page